Directory
>
Susan Low
Susan Low
Senior Vice President | eGenesis, Inc.
Cambridge, Massachusetts, United States
Susan Low
Summary
Susan Low is a seasoned pharmacologist and toxicologist with a robust background in biologics, small molecules, and nanotherapeutics, specializing in the development of oral extended release dosage forms. With extensive experience spanning early research to clinical evaluation in areas such as hemophilia, oncology, and neurological conditions, she has played pivotal roles in various organizations. Currently serving as the Senior Vice President at eGenesis, Inc., she leads xenotransplant development programs, overseeing complex regulatory and clinical activities. Susan's academic foundation includes a PhD from The University of Edinburgh, which complements her practical experience in the pharmaceutical industry. Her expertise extends to project management and toxicology, particularly in oncology and immunology. Beyond her technical skills, she is recognized for her leadership in advancing innovative therapeutic solutions that enhance patient adherence to medication. Susan's career reflects a commitment to scientific excellence and a passion for improving healthcare outcomes.
Susan Low
Work Experience
Senior Vice President at
eGenesis, Inc.
June 2022 - Present
Vice President at
Verseau Therapeutics
July 2019 - Present
Vice President at
eGenesis, Inc.
October 2021 - June 2022
Vice President Pharmacology and Toxicology at
LYNDRA TOV
January 2018 - June 2019
Head of Pharmacology, Toxicology and Biology at
LYNDRA TOV
July 2016 - January 2018
Senior Director at
BIND Therapeutics
March 2013 - April 2016
Head of Biology at
Bind Biosciences Inc.
January 2009 - March 2013
Associate Director, Cell Biology and in vivo Pharmacology at
Syntonix Pharmaceuticals
October 1999 - December 2008
Postdoctoral Scientist at
Massachusetts Institute of Technology
January 1996 - January 1999
Postdoctoral Scientist at
Harvard University
January 1994 - January 1996
Susan Low
Education
The University of Edinburgh, Phd
January 1990 - January 1994
Frequently Asked Questions about Susan Low
What is Susan Low email address?
Susan Low's primary email address is *****@verseautx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Susan Low work for?
Susan Low is a Senior Vice President at eGenesis, Inc., a company specializing in Commercial physical research.
Where Susan Low graduated from?
Susan Low holds a degree in Biology from The University of Edinburgh.
How can I directly contact Susan Low?
To contact Susan Low directly, you can use the email address *****@verseautx.com. Complete contact information is available upon registration with Muraena.
Who is Susan Low?
Susan Low is a seasoned pharmacologist and toxicologist with a robust background in biologics, small molecules, and nanotherapeutics, specializing in the development of oral extended release dosage forms. With extensive experience spanning early research to clinical evaluation in areas such as hemophilia, oncology, and neurological conditions, she has played pivotal roles in various organizations. Currently serving as the Senior Vice President at eGenesis, Inc., she leads xenotransplant development programs, overseeing complex regulatory and clinical activities. Susan's academic foundation includes a PhD from The University of Edinburgh, which complements her practical experience in the pharmaceutical industry. Her expertise extends to project management and toxicology, particularly in oncology and immunology. Beyond her technical skills, she is recognized for her leadership in advancing innovative therapeutic solutions that enhance patient adherence to medication. Susan's career reflects a commitment to scientific excellence and a passion for improving healthcare outcomes.
Susan`s contact details
*****@verseautx.com
Colleagues
Vice President, Quality
Vice President of Intellectual Property & Legal
SVP, Research
Chief Business Officer
President and CEO
Board Member